<!DOCTYPE html>
<html>
<head>
    <link rel="icon" href="Aceso A.png" type="image/x-icon">
    <link href="blogstyle.css" rel="stylesheet" type="text/css"/>
    <script src="https://kit.fontawesome.com/bc064f3ec5.js" crossorigin="anonymous"></script>
<title>APVO</title>
</head>
<!--Post content-->
<section class="post-header">
    <div class="header-content post-container">
        <!--Back to home-->
        <a href="index.html" class="back-home"></a>
        <!--Title-->
        <h1 class="header-title">Aptevo Therapeutics</h1>
        <!--Post Image-->
        <img src="apvo.png" alt="" class="header-img">
    </div>
</section>




    <nav>
        <a href="index.html"class="logo">Aceso</a>
        <ul>
            <li><a href="index.html">Home</a></li>
            <li><a href="about.html">About</a></li>
            <li><a href="contact.html">Contact</a></li>
            <li><a href="disclaimer.html">Disclaimer</a></li>
        </ul>
    </nav>

<!--Posts-->
    <section class="post-content post-container">
        <h2 class="sub-heading">Company Description</h2>
        <p class="post-text">The Company
            Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.
            
            Based in Seattle, Washington, the company is notable for its empowering work environment, entrepreneurial culture, proprietary platform technologies and success in recruiting some of the most innovative minds in the industry.
            
            The Pipeline
            Two clinical candidates. Three preclinical candidates. All in development to improve outcomes for cancer patients.</p>
    </section>

<!--Footer-->
<div class="footer container">
    <p>&#169; Aceso All Rights Reserved</p>
</div>

    



